End Stage Liver Cancer
Links shared publicly online about this topic
The Associated Press: Pfizer ends trial of Sutent in liver cancer
google.com — “The Associated Press: Pfizer ends trial of Sutent in liver cancer” View full resource at google.com
Most Recently Shared on April 23, 2010 at 1:48 pm By:
Pfizer stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer due to adverse effects: http://bit.ly/aOT8bh
Encourage Meditation in Minutes | liver cancer stage
livercancer-stage.com — “Simple guided meditation is a quite useful method that every person should find out. It offers so many advantages to the entire body, head and soul. It can aid” View full resource at livercancer-stage.com
Most Recently Shared on July 27, 2010 at 2:37 pm By:
Encourage Meditation in Minutes | liver cancer stage http://bit.ly/bnEnTx
New Approaches To The Treatment Of Early-stage Liver Cancer
medicalnewstoday.com — “Scientists at the Helmholtz Zentrum München have played a major role in two studies that could fundamentally change the medical treatment of liver cancer. Doctors are now able to determine the de” View full resource at medicalnewstoday.com
Most Recently Shared on November 12, 2011 at 8:05 am By:
New Approaches To The Treatment Of Early-stage Liver Cancer http://t.co/T0VxR4Qu #liver #hepatitis
Cell Transplantation Reports A Success In Treating End-Stage Liver Disease
medicalnewstoday.com — “Transplanting their own (autologous) bone marrow-derived stem cells into 48 patients with end-stage liver disease resulted in therapeutic benefit to a high number of the patients, report research” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2011 at 1:05 pm By:
Cell Transplantation Reports A Success In Treating End-Stage Liver Disease http://mnt.to/3PW7 #healthnews
Pfizer ends late-stage lung-cancer study | Reuters
reuters.com — “NEW YORK (Reuters) - Pfizer Inc said on Tuesday it has ended a late-stage lung cancer study of its experimental drug figitumumab after an analysis showed it was unlikely to meet the main goal of improving” View full resource at reuters.com
Most Recently Shared on December 30, 2009 at 1:47 pm By:
Lisa Jarvis Science Enthusiast
Pfizer ends PhIII trial of figitumumab in lung cancer: http://bit.ly/8lTlsa
Hepatocellular Carcinoma (Liver Cancer)
medicinenet.com — “Get information on liver cancer, its symptoms, causes, diagnosis, staging, prognosis, treatment, and prevention.” View full resource at medicinenet.com
Most Recently Shared on November 27, 2008 at 1:14 am By:
Pfizer ends late-stage lung-cancer study | Reuters
reuters.com — “NEW YORK (Reuters) - Pfizer Inc said on Tuesday it has ended a late-stage lung cancer study of its experimental drug figitumumab after an analysis showed it was unlikely to meet the main goal of improving” View full resource at reuters.com
Most Recently Shared on December 29, 2009 at 11:04 pm By:
HealthIT Policy Health News and Health IT
Pfizer ends late-stage lung-cancer study: NEW YORK (Reuters) - Pfizer Inc said on Tuesday it has ended a late-s.. http://bit.ly/5OgKsZ
Pfizer ends late-stage lung-cancer study | Reuters
reuters.com — “NEW YORK (Reuters) - Pfizer Inc said on Tuesday it has ended a late-stage lung cancer study of its experimental drug figitumumab after an analysis showed it was unlikely to meet the main goal of improving” View full resource at reuters.com
Most Recently Shared on December 29, 2009 at 11:03 pm By:
Pfizer ends late-stage lung-cancer study: NEW YORK (Reuters) - Pfizer Inc said on Tuesday it has .. http://bit.ly/7XsW2f #health #news
Y-90 radioembolization offers promise for late-stage liver cancer
physorg.com — “The latest weapon against inoperable liver cancer is so tiny that it takes millions of them per treatment, but according to interventional radiologists at the Indiana University School of Medicine, those microscopic spheres really pack a therapeutic punch.” View full resource at physorg.com
Most Recently Shared on December 14, 2010 at 11:35 pm By:
Y-90 radioembolization offers promise for late-stage liver cancer http://bit.ly/hLuTbn
Two Proteins May Be Key to Early-Stage Liver Cancer Screening - National Cancer Institute
cancer.gov — “Researchers have identified an improved method of screening high-risk patients for one of the most common types of liver cancer, hepatocellular carcinoma (HCC), particularly if the patient has a history of hepatitis. By changing the threshold of one comm” View full resource at cancer.gov
Most Recently Shared on July 2, 2009 at 6:10 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
RT @Brookewang NCI News: Two Proteins May Be Key to Screening for Early-Stage Liver Cancer http://bit.ly/2rIQWD
Symposier - Management of Renal Failure in End Stage Liver Disease
symposier.com — “This program from UCSF is part of an annual update for physicians who care for liver failure/transplant patients. UCSF is a national leader among abdominal organ transplant programs. This segment covers the management of renal failure in end stage liver disease patients. Series: "UCSF Transplant Update" [2/2008] [Health and Medicine] [Professional Medical Education] [Show ID: 14085]” View full resource at symposier.com
Most Recently Shared on February 3, 2011 at 12:47 am By:
Symposier Nephrology Health Business and Nephrology
Management of Renal Failure in End Stage Liver Disease. Flavio vinventi MD. http://bit.ly/9VVgSX
Prostate Cancer Research Reaches End of First Stage - Topix
topix.com — “Prostate Cancer Research Reaches End of First Stage - Topix” View full resource at topix.com
Most Recently Shared on May 5, 2011 at 7:49 am By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Prostate Cancer Research Reaches End of First Stage: Guernsey volunteers will again be turning out in force over... http://bit.ly/jmFcJZ
Pfizer ends late-stage lung-cancer study | Reuters
feeds.reuters.com — “NEW YORK (Reuters) - Pfizer Inc said on Tuesday it has ended a late-stage lung cancer study of its experimental drug figitumumab after an analysis showed it was unlikely to meet the main goal of improving” View full resource at feeds.reuters.com
Most Recently Shared on December 29, 2009 at 11:03 pm By:
Pfizer ends late-stage lung-cancer study http://link.reuters.com/cep98g
Key pathway in end-stage prostate cancer tumor progression blocked
eurekalert.org — “Researchers at UT Southwestern Medical Center have found that blocking one of the enzymatic steps that allow a prostate tumor to produce androgens could be the key in halting a tumor's growth.” View full resource at eurekalert.org
Most Recently Shared on July 20, 2010 at 8:36 pm By:
Key pathway in end-stage prostate cancer tumor progression blocked http://bit.ly/aFHxgg
Key pathway in end-stage prostate cancer tumor progression blocked
physorg.com — “Prostate cancer advances when tumors become resistant to hormone therapy, which is the standard treatment for patients, and begin producing their own androgens.” View full resource at physorg.com
Most Recently Shared on July 20, 2010 at 8:30 pm By:
PhysOrg Health News Health News
Key pathway in end-stage prostate cancer tumor progression blocked http://tw.physorg.com/198861484
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
Meditation News
Live Meditation News!
-
MNT Liver Disease
The latest liver disease / hepatitis news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
